{"id":"W4388621275","doi":"10.1159/000534303","title":"Second-Line Treatment after Failure of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Tyrosine Kinase Inhibitor, Retrial of Immunotherapy, or Locoregional Therapy?","year":2023,"lang":"en","type":"article","venue":"Liver Cancer","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Hepatocellular carcinoma; Internal medicine; Oncology; Bevacizumab; Atezolizumab; Nivolumab; Adverse effect; Immunotherapy; Gastroenterology; Cancer; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002624538,0.0004260118,0.0009505245,0.0004841353,0.00003922767,0.00001067251,0.0001180859,0.0002542975,0.00240563],"category_scores_gemma":[0.0000167231,0.0003068399,0.0005644137,0.001058313,0.0001859275,0.0001076953,0.00005822553,0.0001932885,0.0000246866],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003725423,"about_ca_system_score_gemma":0.0004522465,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002333048,"about_ca_topic_score_gemma":0.0004622149,"domain_scores_codex":[0.9975601,0.0001071847,0.0009773202,0.0004748376,0.0004440601,0.0004364384],"domain_scores_gemma":[0.9988025,0.0000885804,0.0003017554,0.0005045698,0.0001749373,0.0001275996],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.009757154,0.0008970641,0.8268126,0.0002872036,0.0003832896,0.001019862,0.002027643,0.000003203781,0.1494666,0.00000945096,0.0002592227,0.0090767],"study_design_scores_gemma":[0.01755902,0.003074773,0.1780502,0.0006985008,0.0001635906,0.00002077045,0.0001683678,0.000838878,0.793117,0.00002002744,0.005943901,0.0003449863],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9736761,0.02366957,0.000003164467,0.0004791569,0.0003147325,0.001567028,0.0001795774,0.00005428861,0.00005637171],"genre_scores_gemma":[0.9925082,0.00466307,0.0001346595,0.00005830297,0.0004465631,0.0005841372,0.0001860188,0.00007718821,0.001341862],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6487625,"threshold_uncertainty_score":0.9999384,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05778974049913274,"score_gpt":0.2666817629775639,"score_spread":0.2088920224784312,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}